Subretinal drusenoid deposits: Marker for unrecognized cardiac disease
New research reveals subretinal drusenoid deposits as potential indicators of serious heart disease, highlighting the need for ophthalmologists to screen patients effectively.
Related Articles
NEI-funded researchers test new visual prosthesis system to restore vision | National Eye Institute
Brown University researchers have identified a promising new approach that may help to restore vision in people affected by macular degeneration and other retinal disorders.
Single
Nearly one in five cases of dementia could be related to vision loss, according to a new analysis. The findings suggest that better vision care…
Metabolic Dysfunction in Glaucoma – Eyetube
Flora Hui, PhD, and Pete A. Williams, PhD, recap their article, “Metabolic Dysfunction in Glaucoma: From Bench to Bedside (and Back Again),” which was featured…
How to Submit Your Research Paper to the JAMA Network
Ever wonder what happens to your manuscript after you submit it? From manuscript submission and peer review to all the ways we improve and promote…
OPGX-LCA5 gene therapy phase 1/2 data support potential to restore meaningful vision
Opus Genetics reveals promising 1-year results from OPGx-LCA5 gene therapy, showing sustained vision improvements in adults with LCA5 retinal degeneration.
ARVO 2025: The first phase 2 study to examine tyrosine kinase inhibitors for wet AMD
Katherine Talcott, MD, a retina specialist at Cleveland Clinic, presented findings on EYP-1901 in the phase 2 DAVIO study.
FDA grants RMAT designation to gene therapy for Leber congenital amaurosis
The FDA granted regenerative medicine advanced therapy designation to OPGx-LCA5 for the treatment of Leber congenital amaurosis due to genetic variations in the LCA5…
Association for Research in Vision and Ophthalmology Annual Meeting
Explore special articles published online first to coincide with presentations at the Association for Research in Vision and Ophthalmology Annual Meeting.
Impact of COVID-19 on Medicare Reimbursement and Glaucoma Procedure Utilization: A Payment-Volume Elasticity and Trends Analysis
To examine how the COVID-19 pandemic impacted the relationship between Medicare reimbursement and glaucoma procedure service volume in the United States.
